Sulfur hexafluoride lipid-type A microspheres: Clinical Trials

13 trials of Sulfur hexafluoride lipid-type A microspheres, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 4 recruiting, 2 terminated, 1 withdrawn. 5 Phase 2, 4 Phase 1, 3 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Recruiting 3, Completed 2
Phase 14Completed 1, Recruiting 1, Terminated 1, Withdrawn 1
Phase 33Completed 2, Terminated 1
Early Phase 11Completed 1

Follow Sulfur hexafluoride lipid-type A microspheres: new trials by email Literature Review of Sulfur hexafluoride lipid-type A microspheres trials Research Report on Sulfur hexafluoride lipid-type A microspheres

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Y-90 Treatment Response Using Transarterial Radioembolization
Lumason, Sonazoid - HCC, Hepatocellular Carcinoma
Phase 2RecruitingThomas Jefferson University302025-09-112026-06-10
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
Sulfur Hexafluoride Lipid Microspheres, Contrast-Enhanced Ultrasound, Transarterial Chemoembolization - Liver Neoplasms
Phase 2Recruitingjohn eisenbrey2662024-08-072026-02-17
Contrast-Enhanced Ultrasound and Shear Wave Elastography for the Treatment of Lymphedema
Lumason, Optison, Definity - Lymphedema Arm
Phase 1CompletedMayo Clinic102022-12-152024-08-21
Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation
Sulfur Hexafluoride Lipid Microspheres, Contrast-Enhanced Ultrasound, Computed Tomography - Recurrent Renal Cell Carcinoma, Renal Cell Carcinoma
Phase 2Recruitingjohn eisenbrey2102022-11-032026-02-17
Contrast Enhanced Ultrasound in COVID-19
Sulfur hexafluoride lipid-type A microspheres - Covid19, Multisystem Inflammatory Syndrome in Children (MIS-C)
Phase 3CompletedChildren's Hospital of Philadelphia42020-12-182024-07-30
CEUS Evaluation of Hypoxic Ischemic Injury
Sulfur hexafluoride lipid-type A microspheres - Hypoxic-Ischemic Encephalopathy, Brain Ischemia Hypoxia
Phase 3CompletedChildren's Hospital of Philadelphia12020-12-012025-05-14
Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses
Contrast-Enhanced Ultrasound, Perflutren Lipid Microspheres, Sulfur Hexafluoride Lipid Microspheres - Breast Carcinoma
Phase 1RecruitingUniversity of Southern California1002020-11-052026-02-02
CEUS Evaluation of Bowel Perfusion in Necrotizing Enterocolitis
Sulfur hexafluoride lipid-type A microspheres - Necrotizing Enterocolitis of Newborn, Bowel Ischemic
Phase 3TerminatedChildren's Hospital of Philadelphia12020-11-042024-11-12
Contrast-Enhanced Ultrasound Diagnosis of Acute Appendicitis
Sulfur hexafluoride lipid-type A microspheres - Appendicitis Acute
Phase 1WithdrawnBoston Children's Hospital2020-07-152020-07-17
The Role of Contrast Enhanced Ultrasound in Appendicitis
Sulfur hexafluoride lipid-type A microspheres - Acute Appendicitis
Phase 2CompletedChildren's Mercy Hospital Kansas City372019-01-042023-09-08
Contrast-Enhanced Ultrasound for Kidney Transplant
Lumason Contrast-Enhanced Ultrasound - Kidney Transplantation
Phase 1TerminatedUniversity of Utah202018-02-212025-12-24
Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis
Contrast-Enhanced Ultrasound, Sulfur Hexafluoride Lipid Microspheres, Ultrasound - Cirrhosis
Early Phase 1CompletedM.D. Anderson Cancer Center92018-01-122020-10-14
Safety of SonoVue on Pulmonary Hemodynamics
SonoVue, Placebo - Pulmonary Hypertension
Phase 2CompletedBracco Diagnostics, Inc362011-04-012016-12-07

Conditions studied

Appendicitis (2)  ·  Liver Neoplasms (2)  ·  Acute Kidney Injury (1)  ·  Breast Neoplasms (1)  ·  COVID-19 (1)  ·  Carcinoma (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Renal Cell (1)  ·  Delayed Graft Function (1)  ·  Fibrosis (1)  ·  Hypertension, Pulmonary (1)  ·  Hypoxia-Ischemia, Brain (1)  ·  pediatric multisystem inflammatory disease, COVID-19 related (1)

Sponsors

Children's Hospital of Philadelphia (3)  ·  john eisenbrey (2)  ·  Boston Children's Hospital (1)  ·  Bracco Diagnostics, Inc (1)  ·  Children's Mercy Hospital Kansas City (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  Thomas Jefferson University (1)  ·  University of Southern California (1)  ·  University of Utah (1)

Countries

United States (13)

Top investigators

Bino A Varghese, PhD (1)  ·  Christine Lee, MD, PhD (1)  ·  Harriet Paltiel, MDCM (1)  ·  Isaac E Hall, M.D. (1)  ·  John Eisenbrey, PhD (1)  ·  Maria Luigia Storto, MD (1)  ·  Misun Hwang, MD (1)  ·  Ott Le (1)  ·  Tolulope Oyetunji, MD (1)

Results publications

PMID 30808770, PMID 35081803, PMID 36030353

NIH funding

KL2TR002539 (1), P30CA014089 (1), P30CA016672 (1), R01CA194307 (1), R01CA195524 (1), R01CA269750 (1), R21CA303648 (1)